Jeisys Medical Inc. (KOSDAQ: 287410)
South Korea
· Delayed Price · Currency is KRW
12,900
+20 (0.16%)
Inactive · Last trade price
on Oct 18, 2024
Jeisys Medical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 52,937 | 48,830 | 39,583 | 34,291 | 17,591 |
Cash & Short-Term Investments | 80,777 | 48,830 | 39,583 | 34,291 | 17,591 |
Cash Growth | 53.59% | 23.36% | 15.43% | 94.94% | - |
Accounts Receivable | 14,000 | 14,042 | 10,343 | 6,872 | 3,338 |
Other Receivables | 3,511 | 1,206 | 547.42 | 500.5 | 885.63 |
Receivables | 17,831 | 15,575 | 10,915 | 7,401 | 4,406 |
Inventory | 27,269 | 22,617 | 20,380 | 10,578 | 5,766 |
Prepaid Expenses | 797.51 | 2,436 | 2,077 | 1,014 | 272.14 |
Other Current Assets | 1,929 | 1,052 | 1,528 | 888.94 | 228.77 |
Total Current Assets | 128,604 | 90,510 | 74,483 | 54,173 | 28,264 |
Property, Plant & Equipment | 39,571 | 34,660 | 22,140 | 10,750 | 8,753 |
Long-Term Investments | 30,382 | 9,528 | 7,748 | 258.39 | 698.72 |
Other Intangible Assets | 1,765 | 1,905 | 1,708 | 969.38 | 844.03 |
Long-Term Deferred Tax Assets | 2,384 | 4,097 | 10,938 | 6,991 | 228.67 |
Other Long-Term Assets | 2,123 | 1,612 | 1,100 | 916.86 | 378.05 |
Total Assets | 204,829 | 142,313 | 118,118 | 74,059 | 39,167 |
Accounts Payable | 4,345 | 3,512 | 2,310 | 2,364 | 1,308 |
Accrued Expenses | 2,726 | 2,899 | 3,827 | 2,586 | 1,534 |
Short-Term Debt | 41,312 | 1,304 | 3,287 | 3,257 | 3,257 |
Current Portion of Long-Term Debt | 539.27 | 590.73 | 598.12 | 6,578 | 591.4 |
Current Portion of Leases | 1,248 | 1,441 | 1,063 | 787.46 | 577.78 |
Current Income Taxes Payable | 1,708 | 246.76 | 6,295 | 768.52 | 797.27 |
Current Unearned Revenue | 63 | 55.91 | 41.68 | - | - |
Other Current Liabilities | 12,414 | 13,469 | 9,162 | 7,686 | 4,853 |
Total Current Liabilities | 64,355 | 23,519 | 26,583 | 24,027 | 12,918 |
Long-Term Debt | 26,579 | 21,083 | 10,110 | 1,034 | 7,611 |
Long-Term Leases | 745.5 | 1,188 | 1,205 | 694.96 | 514.02 |
Other Long-Term Liabilities | 259.29 | 273.38 | 264.2 | 649.32 | 245.4 |
Total Liabilities | 91,938 | 46,063 | 38,163 | 26,405 | 22,208 |
Common Stock | 7,671 | 7,647 | 7,130 | 7,130 | 3,043 |
Additional Paid-In Capital | 27,214 | 26,271 | 26,421 | 26,849 | 20,200 |
Retained Earnings | 74,849 | 58,796 | 33,995 | 6,865 | -6,587 |
Treasury Stock | -10,265 | -10,265 | -263.7 | -263.7 | - |
Comprehensive Income & Other | 11,960 | 12,557 | 12,135 | 6,505 | 303.42 |
Total Common Equity | 111,430 | 95,006 | 79,418 | 47,086 | 16,959 |
Minority Interest | 1,461 | 1,243 | 536.97 | 567.94 | - |
Shareholders' Equity | 112,891 | 96,250 | 79,955 | 47,654 | 16,959 |
Total Liabilities & Equity | 204,829 | 142,313 | 118,118 | 74,059 | 39,167 |
Total Debt | 70,423 | 25,606 | 16,263 | 12,351 | 12,551 |
Net Cash (Debt) | 10,353 | 23,224 | 23,320 | 21,940 | 5,039 |
Net Cash Growth | -71.99% | -0.41% | 6.29% | 335.39% | - |
Net Cash Per Share | 134.06 | 300.07 | 304.12 | 284.94 | 92.25 |
Filing Date Shares Outstanding | 75.5 | 75.26 | 71.17 | 71.17 | 4.24 |
Total Common Shares Outstanding | 75.5 | 75.26 | 71.17 | 71.17 | 4.24 |
Working Capital | 64,250 | 66,991 | 47,900 | 30,146 | 15,346 |
Book Value Per Share | 1475.83 | 1262.33 | 1115.92 | 661.61 | 4004.58 |
Tangible Book Value | 109,665 | 93,101 | 77,710 | 46,116 | 16,115 |
Tangible Book Value Per Share | 1452.46 | 1237.02 | 1091.92 | 647.99 | 3805.28 |
Land | 4,336 | 4,336 | 4,336 | 3,146 | 3,146 |
Buildings | 5,224 | 5,229 | 5,233 | 4,008 | 4,010 |
Machinery | 7,460 | 6,996 | 5,262 | 3,472 | 2,035 |
Construction In Progress | 23,044 | 16,991 | 5,713 | 30.5 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.